The use of NLRP3 Inhibition in fungal Infections might be benefical since targeting the NLRP3 inflammasome may dampen pathological inflammation seen during corticosteroid therapy, potentially reducing tissue damage and controlling excessive cytokine release. The gene discussed is NLRP3; the disease is fungal infectious disease.